0
     

Report Added
Report already added
Depression Drugs Market in India - Industry Outlook and Forecast 2020-2026

Depression Drugs Market in India - Industry Outlook and Forecast 2020-2026

Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression._x000D_
_x000D_
This report contains market size and forecasts of Depression Drugs in India, including the following market information:_x000D_
India Depression Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
Top Five Competitors in India Depression Drugs Market 2019 (%)_x000D_
The global Depression Drugs market was valued at 16380 million in 2019 and is projected to reach US$ 18280 million by 2026, at a CAGR of 2.8% during the forecast period. While the Depression Drugs market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
COVID-19 pandemic has big impact on Depression Drugs businesses, with lots of challenges and uncertainty faced by many players of Depression Drugs in India. This report also analyses and evaluates the COVID-19 impact on Depression Drugs market size in 2020 and the next few years in India_x000D_
Total Market by Segment:_x000D_
India Depression Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions)_x000D_
India Depression Drugs Market Segment Percentages, By Type, 2019 (%)_x000D_
SSRIs_x000D_
SNRIs_x000D_
Others_x000D_
_x000D_
India Depression Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions)_x000D_
India Depression Drugs Market Segment Percentages, By Application, 2019 (%)_x000D_
Hospitals_x000D_
Clinics_x000D_
Others_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Depression Drugs Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Depression Drugs Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Intellipharmaceutics_x000D_
Pfizer_x000D_
Eli Lilly_x000D_
Astrazeneca_x000D_
Lundbeck_x000D_
Allergan_x000D_
GSK_x000D_
Otsuka Pharmaceutical_x000D_
Takeda_x000D_
NHU Group_x000D_
Shionogi_x000D_
APOTEX_x000D_
Kanghong Pharma_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Depression Drugs Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 COVID-19 Impact: India Depression Drugs Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 India Depression Drugs Overall Market Size_x000D_
2.1 India Depression Drugs Market Size: 2020 VS 2026_x000D_
2.2 India Depression Drugs Revenue, Prospects & Forecasts: 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Depression Drugs Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Depression Drugs Companies Ranked by Revenue_x000D_
3.3 India Depression Drugs Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 Top 3 and Top 5 Depression Drugs Companies in India, by Revenue in 2019_x000D_
3.5 India Manufacturers Depression Drugs Product Type_x000D_
3.6 Tier 1, Tier 2 and Tier 3 Depression Drugs Players in India_x000D_
3.6.1 List of India Tier 1 Depression Drugs Companies_x000D_
3.6.2 List of India Tier 2 and Tier 3 Depression Drugs Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Depression Drugs Market Size Markets, 2020 & 2026_x000D_
4.1.2 SSRIs_x000D_
4.1.3 SNRIs_x000D_
4.1.4 Others_x000D_
4.2 By Type - India Depression Drugs Revenue & Forecasts_x000D_
4.2.1 By Type - India Depression Drugs Revenue, 2015-2020_x000D_
4.2.2 By Type - India Depression Drugs Revenue, 2021-2026_x000D_
4.2.3 By Type - India Depression Drugs Revenue Market Share, 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Depression Drugs Market Size, 2020 & 2026_x000D_
5.1.2 Hospitals_x000D_
5.1.3 Clinics_x000D_
5.1.4 Others_x000D_
5.2 By Application - India Depression Drugs Revenue & Forecasts_x000D_
5.2.1 By Application - India Depression Drugs Revenue, 2015-2020_x000D_
5.2.2 By Application - India Depression Drugs Revenue, 2021-2026_x000D_
5.2.3 By Application - India Depression Drugs Revenue Market Share, 2015-2026_x000D_
6 Players Profiles_x000D_
6.1 Intellipharmaceutics_x000D_
6.1.1 Intellipharmaceutics Corporate Summary_x000D_
6.1.2 Intellipharmaceutics Business Overview_x000D_
6.1.3 Intellipharmaceutics Depression Drugs Major Product Offerings_x000D_
6.1.4 Intellipharmaceutics Revenue in India (2015-2020)_x000D_
6.1.5 Intellipharmaceutics Key News_x000D_
6.2 Pfizer_x000D_
6.2.1 Pfizer Corporate Summary_x000D_
6.2.2 Pfizer Business Overview_x000D_
6.2.3 Pfizer Depression Drugs Major Product Offerings_x000D_
6.2.4 Pfizer Revenue in India (2015-2020)_x000D_
6.2.5 Pfizer Key News_x000D_
6.3 Eli Lilly_x000D_
6.3.1 Eli Lilly Corporate Summary_x000D_
6.3.2 Eli Lilly Business Overview_x000D_
6.3.3 Eli Lilly Depression Drugs Major Product Offerings_x000D_
6.3.4 Eli Lilly Revenue in India (2015-2020)_x000D_
6.3.5 Eli Lilly Key News_x000D_
6.4 Astrazeneca_x000D_
6.4.1 Astrazeneca Corporate Summary_x000D_
6.4.2 Astrazeneca Business Overview_x000D_
6.4.3 Astrazeneca Depression Drugs Major Product Offerings_x000D_
6.4.4 Astrazeneca Revenue in India (2015-2020)_x000D_
6.4.5 Astrazeneca Key News_x000D_
6.5 Lundbeck_x000D_
6.5.1 Lundbeck Corporate Summary_x000D_
6.5.2 Lundbeck Business Overview_x000D_
6.5.3 Lundbeck Depression Drugs Major Product Offerings_x000D_
6.5.4 Lundbeck Revenue in India (2015-2020)_x000D_
6.5.5 Lundbeck Key News_x000D_
6.6 Allergan_x000D_
6.6.1 Allergan Corporate Summary_x000D_
6.6.2 Allergan Business Overview_x000D_
6.6.3 Allergan Depression Drugs Major Product Offerings_x000D_
6.6.4 Allergan Revenue in India (2015-2020)_x000D_
6.6.5 Allergan Key News_x000D_
6.7 GSK_x000D_
6.6.1 GSK Corporate Summary_x000D_
6.6.2 GSK Business Overview_x000D_
6.6.3 GSK Depression Drugs Major Product Offerings_x000D_
6.4.4 GSK Revenue in India (2015-2020)_x000D_
6.7.5 GSK Key News_x000D_
6.8 Otsuka Pharmaceutical_x000D_
6.8.1 Otsuka Pharmaceutical Corporate Summary_x000D_
6.8.2 Otsuka Pharmaceutical Business Overview_x000D_
6.8.3 Otsuka Pharmaceutical Depression Drugs Major Product Offerings_x000D_
6.8.4 Otsuka Pharmaceutical Revenue in India (2015-2020)_x000D_
6.8.5 Otsuka Pharmaceutical Key News_x000D_
6.9 Takeda_x000D_
6.9.1 Takeda Corporate Summary_x000D_
6.9.2 Takeda Business Overview_x000D_
6.9.3 Takeda Depression Drugs Major Product Offerings_x000D_
6.9.4 Takeda Revenue in India (2015-2020)_x000D_
6.9.5 Takeda Key News_x000D_
6.10 NHU Group_x000D_
6.10.1 NHU Group Corporate Summary_x000D_
6.10.2 NHU Group Business Overview_x000D_
6.10.3 NHU Group Depression Drugs Major Product Offerings_x000D_
6.10.4 NHU Group Revenue in India (2015-2020)_x000D_
6.10.5 NHU Group Key News_x000D_
6.11 Shionogi_x000D_
6.11.1 Shionogi Corporate Summary_x000D_
6.11.2 Shionogi Depression Drugs Business Overview_x000D_
6.11.3 Shionogi Depression Drugs Major Product Offerings_x000D_
6.11.4 Shionogi Revenue in India (2015-2020)_x000D_
6.11.5 Shionogi Key News_x000D_
6.12 APOTEX_x000D_
6.12.1 APOTEX Corporate Summary_x000D_
6.12.2 APOTEX Depression Drugs Business Overview_x000D_
6.12.3 APOTEX Depression Drugs Major Product Offerings_x000D_
6.12.4 APOTEX Revenue in India (2015-2020)_x000D_
6.12.5 APOTEX Key News_x000D_
6.13 Kanghong Pharma_x000D_
6.13.1 Kanghong Pharma Corporate Summary_x000D_
6.13.2 Kanghong Pharma Depression Drugs Business Overview_x000D_
6.13.3 Kanghong Pharma Depression Drugs Major Product Offerings_x000D_
6.13.4 Kanghong Pharma Revenue in India (2015-2020)_x000D_
6.13.5 Kanghong Pharma Key News_x000D_
6.14 HUAHAI_x000D_
6.14.1 HUAHAI Corporate Summary_x000D_
6.14.2 HUAHAI Depression Drugs Business Overview_x000D_
6.14.3 HUAHAI Depression Drugs Major Product Offerings_x000D_
6.14.4 HUAHAI Revenue in India (2015-2020)_x000D_
6.14.5 HUAHAI Key News_x000D_
_x000D_
7 Key Market Trends & Influences 2021-2026_x000D_
7.1 PESTLE Analysis for India Depression Drugs Market_x000D_
7.2 Market Opportunities & Trends_x000D_
7.3 Market Drivers_x000D_
7.4 Market Restraints_x000D_
_x000D_
8 Conclusion_x000D_
_x000D_
9 Appendix_x000D_
9.1 Note_x000D_
9.2 Examples of Clients_x000D_
9.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Depression Drugs in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Depression Drugs Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Depression Drugs Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Depression Drugs Sales by Companies, (K Units), 2015-2020_x000D_
Table 6. India Depression Drugs Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Depression Drugs Price (2015-2020) (US$/Unit)_x000D_
Table 8. India Manufacturers Depression Drugs Product Type_x000D_
Table 9. List of India Tier 1 Depression Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Depression Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Depression Drugs Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Depression Drugs Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Depression Drugs Sales in India (K Units), 2015-2020_x000D_
Table 14. By Type - Depression Drugs Sales in India (K Units), 2021-2026_x000D_
Table 15. By Application - Depression Drugs Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Depression Drugs Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Depression Drugs Sales in India, (K Units), 2015-2020_x000D_
Table 18. By Application - Depression Drugs Sales in India, (K Units), 2021-2026_x000D_
Table 19. Intellipharmaceutics Corporate Summary_x000D_
Table 20. Intellipharmaceutics Depression Drugs Product Offerings_x000D_
Table 21. Intellipharmaceutics Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 22. Pfizer Corporate Summary_x000D_
Table 23. Pfizer Depression Drugs Product Offerings_x000D_
Table 24. Pfizer Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 25. Eli Lilly Corporate Summary_x000D_
Table 26. Eli Lilly Depression Drugs Product Offerings_x000D_
Table 27. Eli Lilly Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 28. Astrazeneca Corporate Summary_x000D_
Table 29. Astrazeneca Depression Drugs Product Offerings_x000D_
Table 30. Astrazeneca Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 31. Lundbeck Corporate Summary_x000D_
Table 32. Lundbeck Depression Drugs Product Offerings_x000D_
Table 33. Lundbeck Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 34. Allergan Corporate Summary_x000D_
Table 35. Allergan Depression Drugs Product Offerings_x000D_
Table 36. Allergan Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 37. GSK Corporate Summary_x000D_
Table 38. GSK Depression Drugs Product Offerings_x000D_
Table 39. GSK Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 40. Otsuka Pharmaceutical Corporate Summary_x000D_
Table 41. Otsuka Pharmaceutical Depression Drugs Product Offerings_x000D_
Table 42. Otsuka Pharmaceutical Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 43. Takeda Corporate Summary_x000D_
Table 44. Takeda Depression Drugs Product Offerings_x000D_
Table 45. Takeda Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 46. NHU Group Corporate Summary_x000D_
Table 47. NHU Group Depression Drugs Product Offerings_x000D_
Table 48. NHU Group Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 49. Shionogi Corporate Summary_x000D_
Table 50. Shionogi Depression Drugs Product Offerings_x000D_
Table 51. Shionogi Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 52. APOTEX Corporate Summary_x000D_
Table 53. APOTEX Depression Drugs Product Offerings_x000D_
Table 54. APOTEX Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 55. Kanghong Pharma Corporate Summary_x000D_
Table 56. Kanghong Pharma Depression Drugs Product Offerings_x000D_
Table 57. Kanghong Pharma Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
Table 58. HUAHAI Corporate Summary_x000D_
Table 59. HUAHAI Depression Drugs Product Offerings_x000D_
Table 60. HUAHAI Depression Drugs Revenue (US$, Mn), (2015-2020)_x000D_
List of Figures_x000D_
Figure 1. Depression Drugs Segment by Type_x000D_
Figure 2. Depression Drugs Segment by Application_x000D_
Figure 3. India Depression Drugs Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Depression Drugs Market Size in India, (US$, Mn): 2020 VS 2026_x000D_
Figure 6. India Depression Drugs Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. The Top 3 and 5 Players Market Share by Depression Drugs Revenue in 2019_x000D_
Figure 8. By Type - India Depression Drugs Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 9. By Type - India Depression Drugs Market Share, 2015-2026_x000D_
Figure 10. By Application - Depression Drugs Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 11. By Application - India Depression Drugs Market Share, 2015-2026_x000D_
Figure 12. PEST Analysis for India Depression Drugs Market in 2020_x000D_
Figure 13. Depression Drugs Market Opportunities & Trends in India_x000D_
Figure 14. Depression Drugs Market Drivers in India_x000D_

Kindly Fill The Form Below

Report Title: Depression Drugs Market in India - Industry Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW